Evidence map›Paper›PMID 42105235›Full record

ArticleCell reports2026

Metadomain and metaloop genome interactions in mammalian T cells.

Gabriel Dolsten, Zhong-Min Wang, Xiao Huang, Susie Song, Michael J Wilson, Xin Yang Bing, Wenfan Ke, Thomas R Cafiero, Amy N Nelson, Sebastian Fernando and 6 more

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Gabriel DolstenLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Zhong-Min WangHoward Hughes Medical Institute and Immunology Program at Sloan Kettering Institute, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Xiao HuangHoward Hughes Medical Institute and Immunology Program at Sloan Kettering Institute, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Susie SongLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Michael J WilsonDepartment of Astrophysical Sciences, Princeton University, Princeton, NJ, USA.
Xin Yang BingLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Wenfan KeLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Thomas R CafieroDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Amy N NelsonDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Sebastian FernandoDepartment of Medicine, Division of Hematology & Oncology and Cancer Genomics and Epigenomics Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Alexander PlossDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Paul SchedlDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Michael S LevineLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Aaron D VinyDepartment of Medicine, Division of Hematology & Oncology and Cancer Genomics and Epigenomics Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Alexander Y RudenskyHoward Hughes Medical Institute and Immunology Program at Sloan Kettering Institute, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yuri PritykinLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA; Department of Computer Science, Princeton University, Princeton, NJ, USA. Electronic address: pritykin@princeton.edu.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Quantitavie and Computational Biology Graduate ProgramT32HG003284 · NHGRI · PRINCETON UNIVERSITY · PI Joshua Michael Akey, Stanislav Y. Shvartsman · 2004 to 2026
$9.9M
Rational design and efficacy testing of vaccines against HCVR01AI168048 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI Alexander Andrianov, Thomas R Fuerst · 2022 to 2026
$7.1M
Visualization of gene activity in the Drosophila embryoR35GM118147 · NIGMS · PRINCETON UNIVERSITY · PI Michael Steven Levine · 2016 to 2026
$6.7M
SELF PEPTIDES BOUND TO MHC CLASS II IN T CELL SELECTIONR01AI034206 · NIAID · UNIVERSITY OF WASHINGTON · PI Alexander Y Rudensky · 1998 to 2026
$6.4M
Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infectionR01AI138797 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PLOSS, ALEXANDER, SU, LISHAN · 2018 to 2022
$3.9M
Data-Driven Mathematical and Computational Modeling of Hepatitis D Infection and Treatment ResponseR01AI146917 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI DAHARI, HAREL · 2020 to 2024
$3.5M
Targeting hepatitis B virus cccDNA during HBV/HIV co-infectionR01AI181664 · NIAID · PRINCETON UNIVERSITY · PI PLOSS, ALEXANDER · 2024 to 2025
$3.0M
Mechanisms of hepatitis B virus cccDNA formationR01AI153236 · NIAID · PRINCETON UNIVERSITY · PI PLOSS, ALEXANDER · 2020 to 2024
$2.8M
The role of the cohesin complex in hematopoietic transformation and leukemia maintenanceR37CA286857 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AARON D VINY · 2023 to 2026
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R37 CA286857NHGRI NIH HHS T32 HG003284NIAID NIH HHS DP2 AI171161NIAID NIH HHS R01 AI034206NIAID NIH HHS R01 AI107301NIAID NIH HHS R01 AI138797NIAID NIH HHS R01 AI146917NIAID NIH HHS R01 AI153236NIAID NIH HHS R01 AI168048NIAID NIH HHS R01 AI181664NIGMS NIH HHS R35 GM118147NIGMS NIH HHS T32 GM007388NIH HHS S10 OD028592
6 · The paper itself

Abstract

Recent studies have advanced understanding of chromosomal organization and its role in gene regulation, yet most analyses focus on short-range interactions (<2 Mb), limiting insight into broader architecture. The relationships between topologically associating domains (TADs), sub-TAD loops, cross-TAD interactions, and chromosomal compartmentalization remain poorly understood. Here, using high-resolution Hi-C analysis, we identify extensive multi-megabase and interchromosomal interactions (metaloops) in T lymphocytes that organize into meta-TAD associations (metadomains). These metaloops connect distal promoters and regulatory elements of genes functionally important in T cells, including Ctla4, Ikzf2, Il2ra, Ets1, and Foxo1. Reanalysis of mouse and human datasets confirms their reproducibility and dependence on superenhancers. Genome-wide clustering reveals three distinct interchromosomal hubs, including a superenhancer-enriched hub linked to T cell-specific gene activation. Integrative analysis of regulatory genomics data identifies factors associated with short- versus long-range interactions. This study introduces a broadly applicable computational framework and reveals features of T cell genome organization.

Indexed as

GenomeT-LymphocytesAnimalsEnhancer Elements, GeneticGene Expression RegulationHumansMicePromoter Regions, Genetic3D chromosomal organizationChIP-seqCP: immunologyCP: molecular biologygene regulationHi-Cinterchromosomal interactionsmetadomainsmetaloopspromoter-enhancer interactionsT cellsTreg cells

Identifiers

PMID42105235
PMCPMC13278674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.